579 results on '"Abate-Shen, Cory"'
Search Results
2. Distinct mesenchymal cell states mediate prostate cancer progression
3. In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis
4. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression
5. Correction: In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis
6. AACR White Paper: Shaping the Future of Cancer Prevention – A Roadmap for Advancing Science and Public Health
7. MP16-18 COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
8. Modeling metastasis in mice: a closer look
9. Castration-mediated IL-8 promotes myeloid infiltration and prostate cancer progression
10. A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance
11. DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis
12. ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
13. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity
14. Composition and Histone Substrates of Polycomb Repressive Group Complexes Change during Cellular Differentiation
15. A Critical Role for p27kip1 Gene Dosage in a Mouse Model of Prostate Carcinogenesis
16. Msx1 Cooperates with Histone H1b for Inhibition of Transcription and Myogenesis
17. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression
18. NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer
19. Cooperativity of Nkx3.1 and Pten Loss of Function in a Mouse Model of Prostate Carcinogenesis
20. Homeobox Genes
21. Abstract 5773: A forward genetic screen identifies SIRT1 as a driver of neuroendocrine prostate cancer
22. Abstract 4115: KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with immune escape and immunotherapy response
23. Supplementary Figures from Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model
24. Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework
25. Table S4 from OncoLoop: A Network-Based Precision Cancer Medicine Framework
26. Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer
27. Correction: ARF Confers a Context-Dependent Response to Chemotherapy in Muscle-Invasive Bladder Cancer
28. Abstract 1116: Identifying neuroendocrine prostate cancer drivers using in vivo forward genetics
29. Supplementary Table S1 from Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model
30. Index of Supplementary Data from OncoLoop: A Network-Based Precision Cancer Medicine Framework
31. Detailed Materials and Methods from OncoLoop: A Network-Based Precision Cancer Medicine Framework
32. Supplementary Figures S1-S11 from OncoLoop: A Network-Based Precision Cancer Medicine Framework
33. Editor's Note: Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model
34. Data from Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model
35. Data from Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
36. Data from ARF Regulates the Stability of p16 Protein Via REGγ-Dependent Proteasome Degradation
37. Supplementary Tables from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
38. Data from ERK and AKT Signaling Drive MED1 Overexpression in Prostate Cancer in Association with Elevated Proliferation and Tumorigenicity
39. Data from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
40. Dataset 1 from Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
41. Supplementary Datasets from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
42. Data from Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer
43. Supplementary Materials and Methods from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
44. Supplementary Data Index from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
45. Supplementary Figures from NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation
46. Supplementary Figures 1 - 4 from ERK and AKT Signaling Drive MED1 Overexpression in Prostate Cancer in Association with Elevated Proliferation and Tumorigenicity
47. Supplementary Figures 1 through 7, Supplementary Tables 1 through 7, and Supplementary Materials and Methods from Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
48. Perspective on this Article from Intravesical Delivery of Rapamycin Suppresses Tumorigenesis in a Mouse Model of Progressive Bladder Cancer
49. Supplementary Materials and Methods, Supplementary Figures 1-6, and Supplementary Tables 1-3 from ARF Regulates the Stability of p16 Protein Via REGγ-Dependent Proteasome Degradation
50. Supplementary Data from Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.